Healthcare provider profile · identity verified

Robert Mac Miley, D.O.

Family Practice · GRAND JUNCTION, CO · NPI 1144519562

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	346	101
Levothyroxine Sodium	Levothyroxine Sodium	276	66
Losartan Potassium	Losartan Potassium	272	74
Omeprazole	Omeprazole	267	64
Lisinopril	Lisinopril	266	70
Amlodipine Besylate	Amlodipine Besylate	197	50
Metformin Hcl	Metformin Hcl	162	45
Tamsulosin Hcl	Tamsulosin Hcl	142	46
Hydrochlorothiazide	Hydrochlorothiazide	134	38
Simvastatin	Simvastatin	124	37
Potassium Chloride	Potassium Chloride	122	31
Metoprolol Succinate	Metoprolol Succinate	118	34
Duloxetine Hcl	Duloxetine Hcl	113	26
Gabapentin	Gabapentin	109	31
Trazodone Hcl	Trazodone Hcl	109	28
Allopurinol	Allopurinol	105	28
Eliquis	Apixaban	94	18
Sertraline Hcl	Sertraline Hcl	94	27
Furosemide	Furosemide	88	24
Pantoprazole Sodium	Pantoprazole Sodium	81	24
Rosuvastatin Calcium	Rosuvastatin Calcium	72	23
Ozempic	Semaglutide	68	12
Fluticasone Propionate	Fluticasone Propionate	63	26
Trulicity	Dulaglutide	62	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	61	22
Zolpidem Tartrate	Zolpidem Tartrate	56	14
Clopidogrel	Clopidogrel Bisulfate	54	11
Celecoxib	Celecoxib	51	11
Famotidine	Famotidine	46	12
Carvedilol	Carvedilol	45	suppressed
Pravastatin Sodium	Pravastatin Sodium	45	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	43	11
Spironolactone	Spironolactone	43	14
Warfarin Sodium	Warfarin Sodium	43	11
Diclofenac Sodium	Diclofenac Sodium	42	14
Fluoxetine Hcl	Fluoxetine Hcl	41	12
Alendronate Sodium	Alendronate Sodium	40	11
Montelukast Sodium	Montelukast Sodium	38	11
Atenolol	Atenolol	36	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	suppressed
Finasteride	Finasteride	35	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	35	suppressed
Metformin Hcl Er	Metformin Hcl	35	12
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	35	suppressed
Jardiance	Empagliflozin	34	suppressed
Mirtazapine	Mirtazapine	34	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	33	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	33	suppressed
Tramadol Hcl	Tramadol Hcl	33	suppressed
Glipizide	Glipizide	32	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	31	suppressed
Baclofen	Baclofen	30	12
Bumetanide	Bumetanide	30	suppressed
Tizanidine Hcl	Tizanidine Hcl	30	suppressed
Xarelto	Rivaroxaban	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	12
Bupropion Xl	Bupropion Hcl	25	suppressed
Cephalexin	Cephalexin	24	12
Primidone	Primidone	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	15
Donepezil Hcl	Donepezil Hcl	23	suppressed
Mupirocin	Mupirocin	23	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	22	suppressed
Lovastatin	Lovastatin	22	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Lorazepam	Lorazepam	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Enalapril Maleate	Enalapril Maleate	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Fluconazole	Fluconazole	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Rybelsus	Semaglutide	18	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Invokana	Canagliflozin	17	suppressed
Citalopram Hbr	Citalopram Hydrobromide	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	suppressed
Diazepam	Diazepam	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Estradiol	Estradiol	16	suppressed
Humalog Kwikpen U-200	Insulin Lispro	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Prednisone	Prednisone	16	13
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Alprazolam	Alprazolam	15	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Clonazepam	Clonazepam	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Premarin	Estrogens, Conjugated	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Butalb-Acetaminoph-Caff-Codein	Butalbit/Acetamin/Caff/Codeine	14	suppressed
Clotrimazole	Clotrimazole	14	suppressed
Diltiazem Hcl	Diltiazem Hcl	14	suppressed
Meloxicam	Meloxicam	14	suppressed
Probenecid	Probenecid	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	13
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Levemir Flexpen	Insulin Detemir	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Omnipod 5 Dexg7g6 Pods (Gen 5)	Insulin Pump Cart,auto,bt,g6/7	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Sildenafil Citrate	Sildenafil Citrate	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Colchicine	Colchicine	12	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Topiramate	Topiramate	12	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error